Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
The Pharmacogenomics Journal|April 22, 2022
Point of care CYP2C19 genotyping after percutaneous coronary interventionLinnea M Baudhuin, Laura J Train, Shaun G Goodman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 22, 2017
Lateralized Basal Ganglia Vulnerability to Pesticide Exposure in Asymptomatic Agricultural WorkersMechelle M Lewis, Nicholas W Sterling, Guangwei Du, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 29, 2006
Functional selectivity and classical concepts of quantitative pharmacologyJonathan D Urban, William P Clarke, Mark von Zastrow, et al.
Schizophrenia Research|June 29, 2007
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophreniaQiwen Mu, Kevin Johnson, Paul S Morgan, et al.
JMIR Formative Research|June 14, 2022
Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention StudyRobert Avram, Derek So, Erin Iturriaga, et al.
Scientific Reports|December 22, 2021
Low plasma serotonin linked to higher nigral iron in Parkinson's diseaseLeslie C Jellen, Mechelle M Lewis, Guangwei Du, et al.
Biomolecules|May 27, 2023
Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's DiseaseMechelle M Lewis, Lauren J Van Scoy, Sol De Jesus, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclaseDavid M Mottola, Jason D Kilts, Mechelle M Lewis, et al.
Cardiovascular Drugs and Therapy|November 29, 2022
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI StudyRoy O Mathew, Mandeep S Sidhu, Charanjit S Rihal, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
MicroRNA Expression in Asymptomatic Welders: Implications for Biomarker Discovery for Environmentally-Linked Neurodegenerative DisordersAlejandra Bargues-Carot, Janina Prado-Rico, Yuka Imamura Kawasawa, et al.
Pageof 12